Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated protein 4 (CTLA-4)

Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated protein 4 (CTLA-4)

US Patent 12110331 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of a canine CD20 positive disease or condition using a canine CD20-spe2025
Compositions and methods for retrieving tumor-related antibodies and antigens2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2023
Fusion proteins and antibodies targeting human red blood cell antigens2023
Human monoclonal autoantibodies to ADAMTS13 and uses thereof2023
Treatment of a canine CD20 positive disease or condition using a canine CD20-spe2021
Anti-TEM1 antibodies and uses thereof2021
Treatment of cancer using GFR α-4 chimeric antigen receptor2020
Anti-TEM1 antibodies and uses thereof2018
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive 2018